Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells

Biochemical and Biophysical Research Communications

Volumn 441, Issue 2, 2013, Pages 405-410

  Matsui, Takanori ^a   Higashimoto, Yuichiro ^a   Taira, Junichi ^a   Yamagishi, Sho Ichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Caveolin 1; Endothelial cells; Inflammation; MALDI TOF mass spectrometry; PEDF

Indexed keywords

CAVEOLIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; VASCULAR CELL ADHESION MOLECULE 1;

ANALYTICAL EQUIPMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

CAVEOLIN-1; ENDOTHELIAL CELLS; INFLAMMATION; MALDI-TOF MASS SPECTROMETRY; PEDF;

ATHEROSCLEROSIS; CAVEOLIN 1; CHEMOKINE CCL2; EYE PROTEINS; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; NERVE GROWTH FACTORS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, SMALL INTERFERING; SERPINS; THROMBOSIS; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA;

EID: 84887987862     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.074     Document Type: Article

References (39)

1. J. Tombran-Tink, C.G. Chader, and L.V. Johnson PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity Exp. Eye Res. 53 1991 411 414
2. D.W. Dawson, O.V. Volpert, and P. Gillis Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 1999 245 248
3. E.J. Duh, H.S. Yang, and I. Suzuma Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth Invest. Ophthalmol. Vis. Sci. 43 2002 821 829
4. S. Yamagishi, Y. Inagaki, and K. Nakamura Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation J. Mol. Cell. Cardiol. 37 2004 497 506
5. S. Yamagishi, T. Matsui, and K. Takenaka Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs) Diabetes Metab. Res. Rev. 25 2009 266 271
6. S.X. Zhang, J.J. Wang, and G. Gao Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor FASEB J. 20 2006 323 325
7. S. Yamagishi, T. Matsui, and K. Nakamura Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties Microvasc. Res. 71 2006 222 226
8. H. Liu, J.G. Ren, and W.L. Cooper Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site Proc. Natl. Acad. Sci. USA 101 2004 6605 6610
9. S. Yamagishi, T. Matsui, and K. Nakamura Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders Curr. Pharm. Des. 15 2009 1027 1033
10. K. Rychli, K. Huber, and J. Wojta Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease Expert Opin. Ther. Targets 13 2009 1295 1302
11. S. Yamagishi, K. Nakamura, and T. Matsui Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression J. Biol. Chem. 281 2006 20213 20220
12. K. Takenaka, S. Yamagishi, and T. Matsui Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes Atherosclerosis 197 2008 25 33
13. K. Nakamura, S. Yamagishi, and T. Matsui Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation Am. J. Pathol. 170 2007 2159 2170
14. S. Ueda, S. Yamagishi, and T. Matsui Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction Am. J. Pathol. 178 2011 591 598
15. G. Sowa Caveolae, caveolins, cavins, and endothelial cell function: new insights Front. Physiol. 2 2012 120
16. T.H. Guan, G. Chen, and B. Gao Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy Diabetologia 56 2013 2068 2077
17. J.B. Michel, O. Feron, and D. Sacks Reciprocal regulation of endothelial nitric oxide synthase by Ca2+-calmodulin and caveolin J. Biol. Chem. 272 1997 15583 15586
18. P.G. Frank, H. Lee, and D.S. Park Genetic ablation of caveolin-1 confers protection against atherosclerosis Arterioscler. Thromb. Vasc. Biol. 24 2004 98 105
19. J. Taira, and Y. Higashimoto Caveolin-1 interacts with protein phosphatase 5 and modulates its activity in prostate cancer cells Biochem. Biophys. Res. Commun. 431 2013 724 728
20. S. Yamagishi, Y. Inagaki, and S. Amano Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochem. Biophys. Res. Commun. 296 2002 877 882
21. M. Wilm, A. Shevchenko, and T. Houthaeve Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry Nature 379 1996 466 469
22. W. Zhang, and B.T. Chait ProFound: an expert system for protein identification using mass spectrometric peptide mapping information Anal. Chem. 72 2000 2482 2489
23. A. Ojima, Y. Ishibashi, and T. Matsui Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression Am. J. Pathol. 182 2013 132 141
24. Y. Ishibashi, T. Matsui, and M. Takeuchi Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression Biochem. Biophys. Res. Commun. 391 2010 1405 1408
25. S. Nakashima, T. Matsui, and S. Yamagishi Pigment epithelium-derived factor (PEDF) blocks high glucose-induced inflammatory reactions in endothelial cells through its anti-oxidative properties Int. J. Cardiol. 168 2013 3004 3006
26. S. Yamagishi, K. Nakamura, and S. Ueda Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF Cell Tissue Res. 320 2005 437 445
27. A. Bernard, J. Gao-Li, and C.A. Franco Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor J. Biol. Chem. 284 2009 10480 10490
28. L. Notari, V. Baladron, and J.D. Aroca-Aguilar Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor J. Biol. Chem. 281 2006 38022 38037
29. C. Fernández-Hernando, J. Yu, and Y. Suárez Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis Cell Metab. 10 2009 48 54
30. C. Fernández-Hernando, J. Yu, and A. Dávalos Endothelial-specific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice Am. J. Pathol. 177 2010 998 1003
31. S. Yamagishi, H. Adachi, and A. Abe Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome J. Clin. Endocrinol. Metab. 91 2006 2447 2450
32. S.V. Petersen, Z. Valnickova, and J.J. Enghild Pigment epithelium-derived factor (PEDF) occurs at a physiologically concentration in human blood: purification and characterization Biochem. J. 374 Pt. 1 2003 199 206
33. J. Gumulec, J. Sochor, and M. Hlavna Caveolin-1 as a potential high-risk prostate cancer biomarker Oncol. Rep. 27 2012 831 841
34. J.A. Doll, V.M. Stellmach, and N.P. Bouck Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas Nat. Med. 9 2003 774 880
35. G. Yang, A.A. Goltsov, and C. Ren Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer Mol. Cancer Res. 10 2012 218 229
36. L. Gu, Y. Okada, and S.K. Clinton Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol. Cell 2 1998 275 281
37. L. Boring, J. Gosling, and M. Cleary Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
38. D.J. Preiss, and N. Sattar Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? Int. J. Clin. Pract. 6 2007 697 701
39. K. Takenaka, S. Yamagishi, and T. Matsui Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes Curr. Neurovasc. Res. 3 2006 73 77